Description

ICL Group Unlocks $350 Million In EBITDA Improvements By 2028; What’s Next?

The International Chemicals Limited (ICL) reported its second quarter 2026 results, evidencing growth in sales, adjusted EBITDA, and net income despite elevated raw material costs and currency headwinds. Consolidated sales increased by 17% year-over-year to $2.1 billion, supported by higher prices across potash, bromine, phosphate fertilizers, and specialty food ingredients. Adjusted EBITDA rose 28% to $448 million, reflecting improved operational efficiency amid a challenging cost environment, including a significant surge in sulfur prices—a key raw material for phosphate products—by over 200% annually. Adjusted net income grew by 35% to $149 million, translating to a 33% rise in adjusted earnings per share. Operating cash flow improved 8% to $290 million, with free cash flow up 34% to $94 million, supported by prudent cost management and discipline. ICL’s four business segments demonstrated mixed performance.